Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on March 26, 2026

SignaBlok to Present Novel Approach to Preventing Pancreatic Cancer Recurrence at the 2026 AACR Annual Meeting
SignaBlok Receives Orphan Drug Designation from FDA for TREM-1 inhibitor for the Treatment of Retinopathy of Prematurity
ARIScience to Collaborate with MSK Therapeutics Accelerator to Advance Novel Precision Small Molecule Therapeutic
Givzey | Version2.ai’s Virtual Engagement Officer (VEO) Surpasses $10 Million in Autonomous Fundraising Revenue
BioVentrix, Inc. Announces German Reimbursement Designation
XORTX Announces Results of  Annual and Special Meeting of Shareholders
DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document
DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2025
Premier Health Announces Results of Shareholders’ Meeting
LeonaBio Reports Full Year 2025 Financial Results and Provides Business Update
DBV Technologies publie ses résultats financiers annuels 2025 et fait le point sur ses activités
DBV Technologies Reports Full Year 2025 Financial Results and Business Update
Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025
XORTX Announces Change of Effective Date of Share Consolidation
Governor Henry McMaster, Open Space Institute, South Carolina State Parks Celebrate the Opening of State’s First-Ever Riverine Park Network
Onco360® Has Been Selected as the National Pharmacy Partner for LIFYORLI™ (relacorilant)
Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria
Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026
NANOBIOTIX publiera ses résultats financiers et opérationnels de l’exercice 2025 le 31 mars 2026

Share this page:

Sign up for:

Massachusetts Healthcare Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.